Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Sensor Monitors Glaucoma

By HospiMedica staff writers
Posted on 05 Sep 2007
A sensor designed to be implanted in the eye could monitor glaucoma by measuring pressure in the eye's interior. More...


The pressure sensor, under development by researchers at Purdue University (West Lafayette, IN, USA) is placed between two layers of tissue in the eye, measures the interocular pressure, and transmits the information to an external receiver, continuously monitoring interocular pressure, instead of measuring it once every six months in the ophthalmologist's office.

One of the major obstacles in creating such a sensor is designing a tiny but highly functional chip that uses very little power. To overcome this problem, the sensor was designing to run on nanowatts rather than on microwatts. The signal is then boosted by a nanoamplifier. The sensor was presented at the Engineering in Medicine and Biology Society's Sciences and Technologies for Health conference, held during August 2007 in Lyon (France). The researchers are planning to conduct animal trials by December 2007 and human trials are planned within 18 months.

"The problem is that your interocular pressure spikes over hours, sometimes minutes. So you can be fine today and fine in six months and spend three months in the middle where it's very high, killing your optic nerve,” said researcher Pedro Irazoqui, Ph.D., an assistant professor of biomedical engineering. "What you really need to do is check it often, every couple of minutes, but you can't go to the doctor every couple of minutes for the rest or your life. So what you need is a device that measures your eye pressure continuously.”

Glaucoma is a group of eye diseases characterized by pressure that causes damage to the optic nerve from glaucoma, and results in loss of peripheral and then central vision. Glaucoma may be treated with medications or surgery to try to stop further damage to the optic nerve and further loss of vision.


Related Links:
Purdue University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.